
Please try another search
Emyria Limited engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia. It develops MDMA-inspired medicines, including EMD-MX1, for faster-acting MDMA with improved side-effect profile for drug-assisted therapies; EMD-MX2, an adjunct for Parkinson’s disease to improve side effects of a common treatment; and EMD-MX3 for other neurological indications. The company is also developing EMD-RX7/9, a CBD capsule prescription medicines for complex pain and anxiety which is under preclinical trial program; and provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the advancement of Emyria’s MDMA analogue drug development program, targeting mental health and neurodegenerative diseases, including Parkinson’s. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Leederville, Australia.
Name | Age | Since | Title |
---|---|---|---|
David Putrino | - | - | Member of Medical Advisory Board |
Jennifer Morgan | - | - | Member of Medical Advisory Board |
Henry William Bosch | - | - | Member of Medical Advisory Board |
Mohit Kaushal | 44 | 2023 | Non-Executive Director |
Nik Zeps | - | - | Member of Medical Advisory Board |
Philip Finch | - | - | Member of Medical Advisory Board |
Richard Magtengaard | - | 2021 | Member of Medical Advisory Board |
John Edward Tooke | 74 | 2020 | Member of Medical Advisory Board & Independent Non-Executive Director |
Karen L. Smith | 56 | 2021 | Non-Executive Director & Chairman of Strategic Advisory Board |
Michael Winlo | - | 2019 | Chief Scientific Officer & Director |
Alistair Vickery | - | 2019 | Executive Medical Director & Director |
Gregory Hutchinson | - | 2023 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review